SB
Shankha Banerjee
About Shankha Banerjee
Data last updated:
Shankha Banerjee is a Ceo at Dr. Lal Pathlabs Limited (since 2024), Director at Paliwal Diagnostics Private Limited (since 2017) and Whole-Time Director at Pathlabs Unifiers Private Limited (since 2021), and holds 6 more current directorships. The companies operate in Healthcare and Life Sciences. The 9 current companies with reported revenue have a combined latest revenue of ₹2,726 Cr; the largest is Dr. Lal Pathlabs Limited at ₹2,555 Cr (FY 2025). Earlier, Shankha Banerjee was a Director at Suburban Diagnostics (India) Private Limited (from 2021) and Director at Paliwal Medicare Private Limited (from 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Ceo | 21 May 2024 | 1995 | ₹2,555 Cr (FY 2025) | Active | |
| Director | 26 Oct 2017 | 1997 | ₹63.57 Cr (FY 2026) | Active | |
| Whole-Time Director | 18 Nov 2021 | 2018 | ₹45.47 Cr (FY 2023) | Active | |
| Director | 19 Nov 2021 | 2019 | ₹25.30 Cr (FY 2025) | Active | |
| Director | 19 Nov 2021 | 2020 | ₹13.33 Cr (FY 2026) | Active | |
| Director | 19 Nov 2021 | 2019 | ₹11.64 Cr (FY 2026) | Active | |
| Director | 01 May 2026 | 2021 | ₹6.90 Cr (FY 2025) | Active | |
| Director | 18 Nov 2021 | 2018 | ₹4.58 Cr (FY 2026) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Nov 2021 | 2002 | ₹171 Cr (FY 2024) | Under Liquidation | |
| Director | 26 Oct 2017 | 2006 | ₹4.88 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shankha Banerjee
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shankha Banerjee
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shankha Banerjee
Shankha Banerjee currently holds 9 directorships: Dr. Lal Pathlabs Limited (Ceo, since 21 May 2024, revenue ₹2,555 Cr (FY 2025)); Paliwal Diagnostics Private Limited (Director, since 26 Oct 2017, revenue ₹63.57 Cr (FY 2026)); Pathlabs Unifiers Private Limited (Whole-Time Director, since 18 Nov 2021, revenue ₹45.47 Cr (FY 2023)); Centrapath Labs Private Limited (Director, since 19 Nov 2021, revenue ₹25.30 Cr (FY 2025)); Chanre Laboratory Private Limited (Director, since 19 Nov 2021, revenue ₹13.33 Cr (FY 2026)); and 4 more.
Shankha Banerjee was first appointed on 26 Oct 2017 as Director at Paliwal Diagnostics Private Limited. The most recent appointment on record is 27 Aug 2026 at Neuome Technologies Private Limited.
The 9 current companies of Shankha Banerjee that report revenue have a combined latest revenue of ₹2,726 Cr: Dr. Lal Pathlabs Limited ₹2,555 Cr (FY 2025); Paliwal Diagnostics Private Limited ₹63.57 Cr (FY 2026); Pathlabs Unifiers Private Limited ₹45.47 Cr (FY 2023); Centrapath Labs Private Limited ₹25.30 Cr (FY 2025); Chanre Laboratory Private Limited ₹13.33 Cr (FY 2026); and 4 more.
Shankha Banerjee held 2 earlier board appointments: Suburban Diagnostics (India) Private Limited (Director, from 12 Nov 2021); Paliwal Medicare Private Limited (Director, from 26 Oct 2017).
The current boards of Shankha Banerjee's companies include Archana Lal Erdmann (Dr. Lal Pathlabs Limited), Arun Duggal (Dr. Lal Pathlabs Limited), Arvind Lal (Dr. Lal Pathlabs Limited), Rahul Sharma (Dr. Lal Pathlabs Limited), Rajit Mehta (Dr. Lal Pathlabs Limited), Rohit Bhasin (Dr. Lal Pathlabs Limited), among others.